
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11948191
[patent_doc_number] => 20170252342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING INSOMNIA'
[patent_app_type] => utility
[patent_app_number] => 15/519676
[patent_app_country] => US
[patent_app_date] => 2015-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22762
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15519676
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/519676 | Compositions and methods for treating insomnia | Oct 20, 2015 | Issued |
Array
(
[id] => 17633843
[patent_doc_number] => 11344548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Analogs of 3,5-dihydroxypentanoate for bone formation
[patent_app_type] => utility
[patent_app_number] => 15/557360
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 9414
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557360
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557360 | Analogs of 3,5-dihydroxypentanoate for bone formation | Oct 7, 2015 | Issued |
Array
(
[id] => 10749707
[patent_doc_number] => 20160095859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'COMBINATION THERAPIES FOR OVERCOMING RESISTANCE TO MITOTIC AGENTS DURING CHEMOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/877203
[patent_app_country] => US
[patent_app_date] => 2015-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 13756
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14877203
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/877203 | Combination therapies for overcoming resistance to mitotic agents during chemotherapy | Oct 6, 2015 | Issued |
Array
(
[id] => 11980882
[patent_doc_number] => 20170285036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'METHODS FOR DETECTING OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/513755
[patent_app_country] => US
[patent_app_date] => 2015-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 12444
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513755
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/513755 | Methods for detecting ovarian cancer | Oct 1, 2015 | Issued |
Array
(
[id] => 14029427
[patent_doc_number] => 10226444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Tissue repair of the nasal mucosa and treatment of rhinitis with alpha-tocpherol compositions
[patent_app_type] => utility
[patent_app_number] => 15/512755
[patent_app_country] => US
[patent_app_date] => 2015-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 2288
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512755
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512755 | Tissue repair of the nasal mucosa and treatment of rhinitis with alpha-tocpherol compositions | Oct 1, 2015 | Issued |
Array
(
[id] => 11479313
[patent_doc_number] => 09585835
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-03-07
[patent_title] => 'Inhalable nicotine formulations and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 14/856102
[patent_app_country] => US
[patent_app_date] => 2015-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11536
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14856102
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/856102 | Inhalable nicotine formulations and methods of making and using the same | Sep 15, 2015 | Issued |
Array
(
[id] => 11942037
[patent_doc_number] => 20170246188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'METHOD OF TREATING ORGANOPHOSPHATE INTOXICATION'
[patent_app_type] => utility
[patent_app_number] => 15/508233
[patent_app_country] => US
[patent_app_date] => 2015-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19441
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508233
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508233 | Method of treating organophosphate intoxication by administration of neurosteroids | Aug 31, 2015 | Issued |
Array
(
[id] => 10812083
[patent_doc_number] => 20160158244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER AND OTHER DISEASES OR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/838878
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8754
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838878
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/838878 | Pharmaceutical compositions for the treatment of cancer and other diseases or disorders | Aug 27, 2015 | Issued |
Array
(
[id] => 12008577
[patent_doc_number] => 09801875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Compositions and methods for weight loss in at risk patient populations'
[patent_app_type] => utility
[patent_app_number] => 14/839792
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6977
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14839792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/839792 | Compositions and methods for weight loss in at risk patient populations | Aug 27, 2015 | Issued |
Array
(
[id] => 11961979
[patent_doc_number] => 20170266132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'METHOD FOR TREATING HYPERHIDROSIS'
[patent_app_type] => utility
[patent_app_number] => 15/505414
[patent_app_country] => US
[patent_app_date] => 2015-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6353
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15505414
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/505414 | Method for treating hyperhidrosis with dexmecamylamine | Aug 19, 2015 | Issued |
Array
(
[id] => 11850164
[patent_doc_number] => 20170224656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'A COMPOSITION FOR THE TREATMENT OF NEUROPATHIES AND/OR NEUROPATHIC PAIN'
[patent_app_type] => utility
[patent_app_number] => 15/503080
[patent_app_country] => US
[patent_app_date] => 2015-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12353
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503080
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503080 | Composition for the treatment of neuropathies and/or neuropathic pain | Aug 17, 2015 | Issued |
Array
(
[id] => 10457903
[patent_doc_number] => 20150342918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS'
[patent_app_type] => utility
[patent_app_number] => 14/824688
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23899
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14824688
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/824688 | Compositions and methods of use of phorbol esters | Aug 11, 2015 | Issued |
Array
(
[id] => 13206983
[patent_doc_number] => 10117842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Methods and materials for reducing ischemia-reperfusion injury
[patent_app_type] => utility
[patent_app_number] => 15/503642
[patent_app_country] => US
[patent_app_date] => 2015-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7653
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503642
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503642 | Methods and materials for reducing ischemia-reperfusion injury | Aug 10, 2015 | Issued |
Array
(
[id] => 10450591
[patent_doc_number] => 20150335605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS'
[patent_app_type] => utility
[patent_app_number] => 14/816674
[patent_app_country] => US
[patent_app_date] => 2015-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12927
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14816674
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/816674 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Aug 2, 2015 | Issued |
Array
(
[id] => 13635187
[patent_doc_number] => 09844543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Method of treating or preventing hyperlipidemia with caffeamide derivatives
[patent_app_type] => utility
[patent_app_number] => 14/800206
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6054
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/800206 | Method of treating or preventing hyperlipidemia with caffeamide derivatives | Jul 14, 2015 | Issued |
Array
(
[id] => 10428888
[patent_doc_number] => 20150313900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/797716
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4199
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14797716
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/797716 | METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY | Jul 12, 2015 | Abandoned |
Array
(
[id] => 11414398
[patent_doc_number] => 09561207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-07
[patent_title] => 'Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation'
[patent_app_type] => utility
[patent_app_number] => 14/795497
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 13876
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795497
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/795497 | Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation | Jul 8, 2015 | Issued |
Array
(
[id] => 10422502
[patent_doc_number] => 20150307513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM'
[patent_app_type] => utility
[patent_app_number] => 14/794417
[patent_app_country] => US
[patent_app_date] => 2015-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8212
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14794417
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/794417 | COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM | Jul 7, 2015 | Abandoned |
Array
(
[id] => 10654649
[patent_doc_number] => 20160000792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS'
[patent_app_type] => utility
[patent_app_number] => 14/793366
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 50039
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793366
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/793366 | Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors | Jul 6, 2015 | Issued |
Array
(
[id] => 11323767
[patent_doc_number] => 20160354378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'Composition for Preventing and Treating Acetaminophen Inducing Hepatotoxicity Containing TNP(N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine) as an Effective Ingredient'
[patent_app_type] => utility
[patent_app_number] => 15/032295
[patent_app_country] => US
[patent_app_date] => 2015-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6145
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15032295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/032295 | Composition for preventing and treating acetaminophen inducing hepatotoxicity containing TNP(N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine) as an effective ingredient | Jul 2, 2015 | Issued |